BOW vs CVS · P/E 16, rev $425.7M vs P/E 16, rev $402.07B
Bowhead Specialty Holdings Inc. (BOW) versus CVS Health Corp (CVS) — a side-by-side from cached financials, not a winner call.
Bowhead Specialty Holdings Inc. (BOW) is a insurance - property & casualty company listed on NYSE.
CVS Health Corp (CVS) is a healthcare plans company listed on US.
Latest reported BOW revenue for 2024-12-31 was $425.7M. Net income was $38.2M. Revenue was up 50.2% from 2023-12-31 to 2024-12-31. BOW currently screens at market cap $903.7M and trailing P/E 15.9.
Latest reported CVS revenue for 2025-12-31 was $402.07B. Net income was $1.77B. Revenue was up 7.8% from 2024-12-31 to 2025-12-31. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
BOW currently screens at market cap $903.7M and trailing P/E 15.9. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
Not investment advice. Open the BOW and CVS stock pages for the full models.
Not investment advice.